These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9669099)
1. Differentiating between natural progesterone and synthetic progestins: clinical implications for premenstrual syndrome and perimenopause management. Martorano JT; Ahlgrimm M; Colbert T Compr Ther; 1998; 24(6-7):336-9. PubMed ID: 9669099 [TBL] [Abstract][Full Text] [Related]
2. Differentiating between natural progesterone and synthetic progestogens: clinical implications for premenstrual syndrome management. Martorano JT; Ahlgrimm M; Myers D Compr Ther; 1993; 19(3):96-8. PubMed ID: 8222594 [No Abstract] [Full Text] [Related]
3. [Progesterone, progestagens in premenstrual syndrome, the perimenopause and the menopause]. Salvat J; Jolles C Praxis (Bern 1994); 1995 Jan; 84(3):70-5. PubMed ID: 7846431 [TBL] [Abstract][Full Text] [Related]
4. [Premenopause or perimenopause. When does it start and how to treat it?]. Rozenbaum H Soins Gynecol Obstet Pueric Pediatr; 1994 Feb; (153):3-6. PubMed ID: 8009388 [No Abstract] [Full Text] [Related]
5. [Progesterone and progestins in premenstrual syndrome, perimenopause, menopause]. Salvat J; Jollès C Rev Med Suisse Romande; 1994 Sep; 114(9):819-24. PubMed ID: 7939115 [No Abstract] [Full Text] [Related]
6. Drugs for the premenstrual syndrome. Drug Ther Bull; 1965 Oct; 3(20):77-9. PubMed ID: 5890656 [No Abstract] [Full Text] [Related]
9. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor. Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561 [TBL] [Abstract][Full Text] [Related]
10. Managing PMS and perimenopause symptoms. The role of compounded medications. Ahlgrimm M Adv Nurse Pract; 2003 May; 11(5):53-4, 90. PubMed ID: 12754984 [No Abstract] [Full Text] [Related]
11. [Pharmacology of progestins]. Michel G; Kuttenn F Rev Prat; 1981 Apr; 31(19):1333-47. PubMed ID: 7233015 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of premenstrual symptoms]. Ylikorkala O Duodecim; 1981; 97(15):1195-8. PubMed ID: 7198965 [No Abstract] [Full Text] [Related]
13. [The role of progesterone and progestins in hydroelectrolytic metabolism (author's transl)]. Elkik F; Mauvais-Jarvis P Nouv Presse Med; 1980 Jan; 9(1):35-8. PubMed ID: 6986604 [TBL] [Abstract][Full Text] [Related]
14. A critical assessment of therapy for the premenstrual tension syndrome. Chakmakjian ZH J Reprod Med; 1983 Aug; 28(8):532-8. PubMed ID: 6415280 [TBL] [Abstract][Full Text] [Related]
15. Progesterone for premenstrual syndrome. Med Lett Drugs Ther; 1984 Nov; 26(674):101-2. PubMed ID: 6387416 [No Abstract] [Full Text] [Related]
16. Medical management of premenstrual dysphoric disorder. Yonkers KA J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853 [TBL] [Abstract][Full Text] [Related]
17. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen. de Lignieres B J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031 [TBL] [Abstract][Full Text] [Related]
18. PMS in the perimenopause. Hassan I; Ismail KM; O'Brien S J Br Menopause Soc; 2004 Dec; 10(4):151-6. PubMed ID: 15667751 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. Wyatt K; Dimmock P; Jones P; Obhrai M; O'Brien S BMJ; 2001 Oct; 323(7316):776-80. PubMed ID: 11588078 [TBL] [Abstract][Full Text] [Related]
20. Micronized progesterone: a new option for women's health care. Wetzel W Nurse Pract; 1999 May; 24(5):62-6, 71, 75-6. PubMed ID: 10349670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]